STOCK TITAN

Protect Pharmaceutical Corp - PRTT STOCK NEWS

Welcome to our dedicated news page for Protect Pharmaceutical (Ticker: PRTT), a resource for investors and traders seeking the latest updates and insights on Protect Pharmaceutical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Protect Pharmaceutical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Protect Pharmaceutical's position in the market.

Rhea-AI Summary
Protect Pharmaceutical Corp. President, Ali Yildiz, announces the completion of the 2021 and 2022 financial audits, with expected total revenues of USD 63.1 Million and USD 81 Million respectively. The company plans to file Form 10 with the SEC, expecting a record-breaking year in revenue and profitability for 2024. They also intend to expand globally and rebrand with a new name and symbol.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.36%
Tags
none
-
Rhea-AI Summary
Protect Pharmaceutical Corp. (PRTT) President, Ali Yildiz, updates shareholders on PCAOB audit progress and increased shipments to Azerbaijan, expecting a positive impact on revenue and profitability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.22%
Tags
none
-
Rhea-AI Summary
Protect Pharmaceutical Corp. (PRTT) CEO Ali Yildiz Addresses Shareholders, Expects Completion of PCAOB Audit and Announces Stock Buyback Program
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.1%
Tags
none
Rhea-AI Summary
Protect Pharmaceutical Corp. (PRTT) CEO Ali Yildiz Provides Shareholder Update: The company has achieved its largest quarter for revenues for the second consecutive quarter, with plans to continue growing and expanding through acquisitions. A share repurchase program of up to $10 million has been approved, funded by available cash flow and future business contracts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.26%
Tags
none
-
Rhea-AI Summary
Protect Pharmaceutical Corp. (PRTT) Acquires Bosfor Export, Boosting Revenue and Market Presence
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Protect Pharmaceutical Corp. CEO Ali Yildiz provides shareholder update, highlighting strong second-quarter revenues of $62 million and operating profit of over $18 million. Expansion plans include new routes in the Black Sea, South America, and Europe. The company aims to become an SEC Reporting Company and eventually uplist to an exchange. A new website is under development. Forward-looking statements caution investors of potential risks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.62%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.7%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.25%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.21%
Tags
none
Protect Pharmaceutical Corp

OTC:PRTT

PRTT Rankings

PRTT Stock Data

2.78M
19.04M
84.31%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Las Vegas